MORTIMER IAN - Insider Non-Derivative Transactions at Xenon Pharmaceuticals Inc. (XENE) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on May 24, 2023, MORTIMER IAN's relationship to Xenon Pharmaceuticals Inc. (XENE) is Director,Officer (PRESIDENT & CEO), and currently has 48,592 shares of Common Shares.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other XENE insiders.
Data Source: SEC.
MORTIMER IAN - Insider Non-Derivative Transactions at XENE
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| May 25, 2023 | Sell -- (Common Shares) | 17069 | 41.44 | 24213 |
| May 25, 2023 | Sell -- (Common Shares) | 13179 | 41.37 | 27708 |
| May 25, 2023 | Sell -- (Common Shares) | 1407 | 41.49 | 31302 |
| May 25, 2023 | F -- (Common Shares) | 1171 | 41.84 | 32709 |
| May 25, 2023 | M -- (Common Shares) | 6172 | 9.85 | 33880 |
| May 25, 2023 | F -- (Common Shares) | 3902 | 41.84 | 40887 |
| May 25, 2023 | F -- (Common Shares) | 7310 | 41.84 | 41282 |
| May 25, 2023 | M -- (Common Shares) | 20576 | 9.85 | 44789 |
| May 25, 2023 | M -- (Common Shares) | 42592 | 9.44 | 48592 |